Fintel reports that on February 12, 2025, HC Wainwright & Co. downgraded their outlook for Inhibikase Therapeutics ...
Fintel reports that on February 12, 2025, Benchmark initiated coverage of Tesla (NasdaqGS:TSLA) with a Buy recommendation.